Open Demat Account
Become a
New
Partner
Products &
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Multinational
Share
Glaxosmithkline Pharmaceuticals Ltd Share Price
Pharmaceuticals - Multinational
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
2,791.90
2,795.40
Date :
Sep 04,2025 10:29:58
+15.00
(0.54 )
+0.79
(22.00 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
2,789.50
Buy (size)
2,791.20(x2)
Sell (size)
2,791.90(×3)
Buy Qty
2
Sell Qty
3
Today's High
(₹)
2,798.90
Today's Low
(₹)
2,752.70
52 Week High
(₹)
3,515.70
52 Week Low
(₹)
1,921.00
Market Statistics
Div Yield (%)
1.95
EPS
55.42
Book Value
115.19
Market Cap
46983.07
Face Value
10
Market Lot
1
AGM Date
Jun
Closure Date
ISIN No
INE159A01016
Share Holding Pattern
Total Foreign (Promoter & Group)
127054524
Indian (Promoter & Group)
0
Total of Promoter
127054524
Non Promoter (Institution)
21327115
Non Promoter (Non-Institution)
21024395
Total Non Promoter
42351510
Total Promoter & Non Promoter
169406034
Custodians(Against Depository Receipts)
0
Grand Total
169406034
News
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Disclos..
25-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Disclosure Under Regulation 30
Company forays into oncology with jemperli & Zejula bringing precision therapies for Gynaecological cancers
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Announc..
25-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Company forays into Oncology with Jemperli & Zejula bringing precisions therapies for Gynaecological Cancers
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
25-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled 'Company forays into Oncology lwith Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers. '.
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
25-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled 'Company forays into Oncology lwith Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers. '.
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
08-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
08-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
06-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - News Verification
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Limited with respect to recent news item captioned Trump Tariff News Live: GSK and AstraZeneca among top companies told to cut US prices or else. The response from the Company is attached.
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Disclos..
05-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Disclosure Under Regulation 30
As per attachment
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSm..
05-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Other General Purpose
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Rumour ..
04-Aug-2025
Read More
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd - Rumour verification - Regulation 30(11)
Clarification on news item appearing in Moneycontrol.com
Corporate Details
Board of Directors
Incorporation Year
1924
Chairman
Renu S Karnad
Auditor
Deloitte Haskins & Sells LLP
Face Value
10
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
NA     
Contact
Telephone: 91-022-24959595
Fax: 91-022-24959494
Non Executive Director
Subesh Williams
Chairperson
Renu S Karnad
Independent Director
Sunita Maheshwari
Manu Anand
Managing Director
Bhushan Akshikar
Whole Time Director & Chief Financial Officer
J. Chandy
Company Sec. & Compli. Officer
A A Nadkarni
Independent Director
Somasundaram Palamadairamaswamy
Anup Wadhawan
Mutual Fund Holdings
1-10
of 125
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
SBI Midcap Fund
430.57
1.91
22,546.50
Kotak Large & Midcap Fund
347.89
1.24
28,084.13
Nippon India Pharma Fund
288.82
3.31
8,736.57
Nippon India Growth Mid Cap Fund
176.79
0.46
38,581.28
Aditya Birla SL ELSS Tax Saver Fund
168.35
1.09
15,456.98
SBI Dividend Yield Fund
142.32
1.57
9,069.77
Kotak Flexi Cap Fund
126.29
0.24
53,293.04
Aditya Birla SL MNC Fund
82.49
2.20
3,755.60
Bandhan ELSS Tax Saver Fund
69.58
1.00
6,973.73
SBI Quant Fund
57.53
1.54
3,736.14
FAQ
What is the share price of Glaxosmithkline Pharmaceuticals Ltd today on NSE and BSE?
The Glaxosmithkline Pharmaceuticals Ltd Share price on NSE is Rs.2,791.90 and BSE Rs.2,795.40 as on today
How to buy Glaxosmithkline Pharmaceuticals Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Glaxosmithkline Pharmaceuticals Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Glaxosmithkline Pharmaceuticals Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Glaxosmithkline Pharmaceuticals Ltd is 46983.07
What are the key financial ratios to analyse Glaxosmithkline Pharmaceuticals Ltd Share Price?
Glaxosmithkline Pharmaceuticals Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 50.04
ROE ratio: 49.23
Debt to Equity ratio: 0.01
EPS: 55.42
When did Glaxosmithkline Pharmaceuticals Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Glaxosmithkline Pharmaceuticals Ltd issued bonus shares last in 2018
What is the 52 week highest and lowest share price value of Glaxosmithkline Pharmaceuticals Ltd?
The highest share price value is Rs. 3,515.70 and Lowest share price value is Rs. 1,921.00 for 52 week period for Glaxosmithkline Pharmaceuticals Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Glaxosmithkline Pharmaceuticals Ltd?
SBI Midcap Fund has the highest amount invested with Glaxosmithkline Pharmaceuticals Ltd.
Which year Glaxosmithkline Pharmaceuticals Ltd was incorporated?
Glaxosmithkline Pharmaceuticals Ltd was incorporated in 1924
What is the stock symbol of Glaxosmithkline Pharmaceuticals Ltd?
The stock symbol for Glaxosmithkline Pharmaceuticals Ltd shares is GLAXOSMITHKLINEPHARMACEUTICALSLTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
Abbott India Ltd
500488
ABBOTINDIA
Astrazeneca Pharma India Ltd
506820
ASTRAZEN
Boehringer Mannheim India Ltd (Merged)
500071
BOERMANHEM
Burroughs Wellcome (India) Ltd (Merged)
500076
BURRWELCOM
Fresenius Kabi Oncology Ltd
532545
FKONCO
Parke Davis (India) Ltd (Merged)
500677
PARKEDAVIS
Pfizer Ltd
500680
PFIZER
Pharmacia Healthcare Ltd(Merged)
506817
PHARMACIA
Procter & Gamble Health Ltd
500126
PGHL
Sanofi Consumer Healthcare India Ltd
544250
SANOFICONR
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
03 Sep 2025
1,28,841.00
61,500.00
47.73
02 Sep 2025
74,423.00
42,420.00
57.00
01 Sep 2025
89,303.00
62,207.00
69.66
29 Aug 2025
70,828.00
44,750.00
63.18
28 Aug 2025
1,45,917.00
1,05,414.00
72.24
26 Aug 2025
1,80,296.00
1,38,483.00
76.81
25 Aug 2025
1,32,460.00
70,958.00
53.57
22 Aug 2025
39,428.00
19,872.00
50.40
21 Aug 2025
1,09,925.00
66,403.00
60.41
20 Aug 2025
1,14,680.00
69,451.00
60.56
19 Aug 2025
1,27,746.00
74,332.00
58.19
18 Aug 2025
1,89,209.00
1,06,644.00
56.36
14 Aug 2025
1,16,849.00
57,199.00
48.95
13 Aug 2025
4,21,339.00
1,40,291.00
33.30
12 Aug 2025
1,41,456.00
94,429.00
66.76
11 Aug 2025
56,444.00
24,675.00
43.72
08 Aug 2025
77,215.00
39,734.00
51.46
07 Aug 2025
1,24,214.00
70,647.00
56.88
06 Aug 2025
90,193.00
53,105.00
58.88
05 Aug 2025
1,00,660.00
66,948.00
66.51
04 Aug 2025
1,43,804.00
70,054.00
48.71
Please wait ...